New applications of cancer immunotherapy

被引:10
作者
Agarwala, SS [1 ]
机构
[1] Univ Pittsburgh, Pittsburgh Canc Inst, Melanoma Ctr, Pittsburgh, PA 15213 USA
关键词
D O I
10.1053/sonc.2002.33082
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1 / 4
页数:4
相关论文
共 53 条
[1]  
Agarwala S S, 2000, Oncologist, V5, P144, DOI 10.1634/theoncologist.5-2-144
[2]  
Agarwala SS, 1999, CANCER, V85, P1979, DOI 10.1002/(SICI)1097-0142(19990501)85:9<1979::AID-CNCR15>3.0.CO
[3]  
2-G
[4]   Results from a randomized phase III study comparing combined treatment with histamine dihydrochloride plus interleukin-2 versus interleukin-2 alone in patients with metastatic melanoma [J].
Agarwala, SS ;
Glaspy, J ;
O'Day, SJ ;
Mitchell, M ;
Gutheil, J ;
Whitman, E ;
Gonzalez, R ;
Hersh, E ;
Feun, L ;
Belt, R ;
Meyskens, F ;
Hellstrand, K ;
Wood, D ;
Kirkwood, JM ;
Gehlsen, KR ;
Naredi, P .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) :125-133
[5]  
ALLEN C, 1985, IMMUNOLOGY, V55, P289
[6]  
*AM CANC SOC, 2000, CANC FACTS FIG 2000
[7]  
Atkins MB, 2000, CANCER J SCI AM, V6, pS11
[8]  
Balch Charles M., 1997, P1947
[9]  
Balch CM, 2000, CANCER-AM CANCER SOC, V88, P1484, DOI 10.1002/(SICI)1097-0142(20000315)88:6<1484::AID-CNCR29>3.0.CO
[10]  
2-D